3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow APT-1011: new trials by email Literature Review of APT-1011 trials Research Report on APT-1011
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE 3) APT-1011, Placebo oral tablet, Esophagogastroduodenoscopy - Eosinophilic Esophagitis | Phase 3 | Completed | Ellodi Pharmaceuticals, LP | 218 | 2022-12-29 | 2025-08-13 |
| Efficacy and Safety APT-1011 in Adolescent Subjects With Eosinophilic Esophagitis (EoE) - A Sub-Study of the FLUTE-2 Trial APT-1011, Placebo oral tablet - Eosinophilic Esophagitis | Phase 3 | Completed | Ellodi Pharmaceuticals, LP | 6 | 2021-09-30 | 2023-09-21 |
| Efficacy and Safety APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2) APT-1011, Placebo oral tablet, Esophagogastroduodenoscopy - Eosinophilic Esophagitis | Phase 3 | Completed | Ellodi Pharmaceuticals, LP | 143 | 2020-01-30 | 2023-06-12 |
Eosinophilia (3) · Eosinophilic Esophagitis (3) · Esophageal Diseases (3) · Esophagitis (3) · Gastroenteritis (3) · Gastrointestinal Diseases (3) · Hematologic Diseases (3) · Hypersensitivity (3) · Hypersensitivity, Immediate (3) · Immune System Diseases (3) · Leukocyte Disorders (3) · Digestive System Diseases (2)
Ellodi Pharmaceuticals, LP (3)
United States (3) · Australia (2) · Canada (1) · Spain (1)
Evan Dellon, MD, MPH (2) · Mirna Chehade, MD, MPH (1)